209971-18-6 Usage
Description
(2-cyanoethyl)methylsulfamyl chloride is a chemical compound that belongs to the class of organic compounds known as sulfamides. It is a sulfamyl chloride derivative that contains a cyano group and a methyl group. (2-cyanoethyl)methylsulfamyl chloride is characterized by its potential to be a useful building block for the synthesis of various pharmaceuticals and other biologically active molecules.
Uses
Used in Pharmaceutical Synthesis:
(2-cyanoethyl)methylsulfamyl chloride is used as a key intermediate in the synthesis of sulfonamides and other sulfur-containing compounds. Its unique structure allows for the creation of a wide range of pharmaceuticals with diverse therapeutic applications.
Used in Organic Synthesis:
In the field of organic synthesis, (2-cyanoethyl)methylsulfamyl chloride serves as a reagent to introduce a sulfamyl chloride moiety into the structure of other organic compounds. This can enhance the properties of these compounds and expand their potential uses in various chemical processes.
Used in Chemical Research:
(2-cyanoethyl)methylsulfamyl chloride is also utilized in chemical research to explore new methods of synthesis and to understand the reactions and properties of sulfamides and related compounds. This can lead to the development of new chemical processes and the discovery of novel compounds with unique properties.
Check Digit Verification of cas no
The CAS Registry Mumber 209971-18-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,9,9,7 and 1 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 209971-18:
(8*2)+(7*0)+(6*9)+(5*9)+(4*7)+(3*1)+(2*1)+(1*8)=156
156 % 10 = 6
So 209971-18-6 is a valid CAS Registry Number.
209971-18-6Relevant articles and documents
CONDENSED PYRROLOPYRIDINE DERIVATIVE
-
Page/Page column 24; 62, (2012/02/15)
[Problem] The present invention provides a condensed pyrrolopyridine derivative which is useful as an active ingredient for a pharmaceutical composition, in particular, a pharmaceutical composition for preventing or treating diseases caused by undesirable cytokine signal transduction or diseases caused by abnormal cytokine signal transduction. [Means for Solution] The present inventors have extensively studied a compound having a JAK inhibitory action, and as a result, they have found that a condensed pyrrolopyridine derivative which is the compound of the present invention has an excellent JAK inhibitory action, and is therefore useful as an agent for preventing or treating diseases caused by undesirable cytokine signal transduction or diseases caused by abnormal cytokine signal transduction, thereby completing the present invention.
